Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- Politecnico di Milano
- Università degli Studi di Brescia
- Istituto Italiano di Tecnologia
- UNICAM
- Università degli Studi di Verona
- ;
- AI4I
- Bocconi University
- Dipartimento di Scienze del Farmaco
- Edmund Mach Foundation
- Fondazione Bruno Kessler
- Hult
- Humanitas Research Hospital
- IMEC
- Istituto Nazionale di Geofisica e Vulcanologia
- Libera Università di Bolzano
- Novac
- SAPIENZA - UNIVERSITA' DI ROMA
- Scuola Internazionale Superiore di Studi Avanzati
- Universita Degli Studi Di Perugia
- Università degli Studi di Catania
- Università degli Studi di Roma Tor Vergata - Dipartimento di Medicina dei Sistemi
- Università degli Studi di Siena
- Università degli Studi di Trento
- 14 more »
- « less
-
Field
-
23 Dec 2025 Job Information Organisation/Company Università degli Studi di Trento Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Application Deadline 12 Jan 2026 -...
-
13 Dec 2025 Job Information Organisation/Company SAPIENZA - UNIVERSITA' DI ROMA Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Application Deadline 11 Jan 2026 - 23:59...
-
Università degli Studi di Roma Tor Vergata - Dipartimento di Medicina dei Sistemi | Italy | about 2 hours ago
cytokines (e.g., IL-23, IL-17, type 2 cytokines), has revolutionized the therapeutic approach. This project aims to explore and disseminate new scientific evidence guiding the use of targeted therapies (e.g
-
5 Dec 2025 Job Information Organisation/Company Libera Università di Bolzano Research Field Agricultural sciences Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Application...
-
factors to reprogram TAMs from pro-tumoral (M2) to anti-tumoral (M1) phenotypes. NCs are engineered for targeted delivery via CD-206 and CD-44 receptors, with controlled release at the tumor site
-
(from Daya Drug Discovery) and one already approved drug (bionanserin) targeting serotonin (5-HT) and/or dopamine (DA) receptors on schizophrenia-related cognitive phenotypes induced by either gene
-
Postdoctoral Researcher to join our research team focused on the in-depth chemical characterization of Medicinal and Aromatic Plants (MAPs). The successful candidate will leverage advanced targeted and
-
18 Oct 2025 Job Information Organisation/Company Scuola Internazionale Superiore di Studi Avanzati Research Field Neurosciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Country Italy Application Deadline 6 Nov...
-
. Developing a new Bayesian, data-driven approach for multidisciplinary geophysical time series analysis to detect anomalies in real time, useful for disaster management managers managing a monitoring network
-
and cyber-physical software; Runtime verification of cyber-physical and autonomous systems; Target applications may include autonomous systems, collision avoidance, mission and plan monitoring